European industry bodies voice concern over CoE's anti-counterfeiting system
This article was originally published in SRA
Executive Summary
Moves towards implementing a Europe-wide system for verifying the authenticity of medicines are gathering pace as representatives of the pharmaceutical industry and distributors prepare to sign an agreement on what they say will be a "practical and cost-effective solution" to implementing the requirements of the new EU legislation on falsified medicines.